Garrison Point Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Garrison Point Advisors's AMGN Position: Q2 2026 in Review
Garrison Point Advisors reduced its Amgen (AMGN) stake by 3.9% in Q2 2026, selling an estimated $75.3K and leaving 5,460 shares worth $1.98M. The position accounts for 0.8% of the portfolio, ranked #32.
Garrison Point Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.1M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Garrison Point Advisors held 5,460 shares of Amgen worth $1.98M as of Q2 2026.
- Garrison Point Advisors sold 220 Amgen shares in Q2 2026, an estimated $75.3K.
- Amgen made up 0.8% of Garrison Point Advisors's portfolio in Q2 2026, its #32 holding.
- Garrison Point Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Garrison Point Advisors's Amgen position peaked at $2.1M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.